418
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

, , , &
Pages 504-514 | Received 09 Sep 2010, Accepted 17 Jan 2011, Published online: 18 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sóstenes Mistro, Lorena Rosa, Bárbara Gomes, Lígia Miranda & Roberto Badaró. (2016) Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses. Expert Review of Pharmacoeconomics & Outcomes Research 16:4, pages 465-473.
Read now
Stuart J Turner, Sharon CA Chen, Monica A Slavin & David CM Kong. (2013) Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients. Expert Review of Pharmacoeconomics & Outcomes Research 13:2, pages 227-235.
Read now

Articles from other publishers (7)

Ken Chen, Qi Wang, Roy A. Pleasants, Long Ge, Wei Liu, Kangning Peng & Suodi Zhai. (2017) Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis. BMC Infectious Diseases 17:1.
Crossref
Hinojal Zazo, Clara I. Colino & José M. Lanao. (2016) Current applications of nanoparticles in infectious diseases. Journal of Controlled Release 224, pages 86-102.
Crossref
S. J. Turner, E. Senol, A. Kara, D. Al-Badriyeh, E. C. Dinleyici & D. C. M. Kong. (2014) Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey. Mycoses 57:8, pages 489-496.
Crossref
Stuart J Turner, Esin Senol, Ates Kara, Daoud Al-Badriyeh, Ener C Dinleyici & David CM Kong. (2013) Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey. BMC Infectious Diseases 13:1.
Crossref
S.J. Turner, E. Senol, A. Kara, D. Al-Badriyeh, D.C.M. Kong & E.C. Dinleyici. (2013) Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey. International Journal of Antimicrobial Agents 42:3, pages 276-280.
Crossref
Me‐Linh Luong, Shahid Husain & Coleman Rotstein. (2013) Pharmacoeconomic assessment of therapy for invasive aspergillosis. Mycoses 56:3, pages 338-349.
Crossref
Beatriz Larru & Theoklis E. Zaoutis. (2013) Newer antifungal agents. Current Opinion in Pediatrics 25:1, pages 110-115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.